A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19
Clinical trial NCT04646044 · COMPLETED
Trial details
- NCT number
- NCT04646044
- Sponsor
- Nektar Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-13
- Primary completion
- 2021-05-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.